Glycyrol targets Pneumolysin (PLY) oligomerization to reduce Streptococcus pneumoniae toxicity
Exploring the potential of glycyrol to reduce the invasiveness of ( ). Cell experiments were performed using A549 alveolar epithelial cells and D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect...
Saved in:
Published in | Frontiers in pharmacology Vol. 15; p. 1478135 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
03.12.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Exploring the potential of glycyrol to reduce the invasiveness of
(
).
Cell experiments were performed using A549 alveolar epithelial cells and
D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate
infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity.
We discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in
invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of
or the production of PLY.
We have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine
Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of
invasion, while not affecting the growth of
and the production of PLY. |
---|---|
AbstractList | Aim of the studyExploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Materials and MethodsCell experiments were performed using A549 alveolar epithelial cells and S. pneumoniae D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate S. pneumoniae infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity.ResultsWe discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in S. pneumoniae invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of S. pneumoniae or the production of PLY.ConclusionWe have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Glycyrrhiza uralensis Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of S. pneumoniae invasion, while not affecting the growth of S. pneumoniae and the production of PLY. Exploring the potential of glycyrol to reduce the invasiveness of ( ). Cell experiments were performed using A549 alveolar epithelial cells and D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity. We discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of or the production of PLY. We have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of invasion, while not affecting the growth of and the production of PLY. Exploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Aim of the studyExploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Cell experiments were performed using A549 alveolar epithelial cells and S. pneumoniae D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate S. pneumoniae infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity.Materials and MethodsCell experiments were performed using A549 alveolar epithelial cells and S. pneumoniae D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate S. pneumoniae infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity.We discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in S. pneumoniae invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of S. pneumoniae or the production of PLY.ResultsWe discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in S. pneumoniae invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of S. pneumoniae or the production of PLY.We have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Glycyrrhiza uralensis Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of S. pneumoniae invasion, while not affecting the growth of S. pneumoniae and the production of PLY.ConclusionWe have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Glycyrrhiza uralensis Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of S. pneumoniae invasion, while not affecting the growth of S. pneumoniae and the production of PLY. |
Author | Li, Yudi Hu, Yibo Wu, Hongji Xu, Yan Meng, Haoji |
AuthorAffiliation | 2 School of Pediatrics , Henan University of Chinese Medicine , Zhengzhou , Henan , China 1 Department of Pediatrics , The First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , Henan , China |
AuthorAffiliation_xml | – name: 2 School of Pediatrics , Henan University of Chinese Medicine , Zhengzhou , Henan , China – name: 1 Department of Pediatrics , The First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , Henan , China |
Author_xml | – sequence: 1 givenname: Yudi surname: Li fullname: Li, Yudi – sequence: 2 givenname: Hongji surname: Wu fullname: Wu, Hongji – sequence: 3 givenname: Yibo surname: Hu fullname: Hu, Yibo – sequence: 4 givenname: Haoji surname: Meng fullname: Meng, Haoji – sequence: 5 givenname: Yan surname: Xu fullname: Xu, Yan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39691402$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkk9v1DAQxS1UREvpF-CAciyHXfwnTuwTQhUtlVaiEnDgguWMJ1tXSRxsB5F-etLdpWp9GWvmze9J9ntNjoYwICFvGV0LofSHdry1cc0pL9esrBUT8gU5YVUlVloxfvTkfkzOUrqjyxFai6p8RY6FrjQrKT8hv666GeYYuiLbuMWcipsBpz50c_JDcX6z-fm-CJ3fhh6jv7fZh6HIoYjoJsDiW4445gABYErFuNscvMVF8teDz_Mb8rK1XcKzQz0lPy4_f7_4stp8vbq--LRZQclpXoF0UDc1oG3LxlGk0OjWKeeo1khRKiWEbeQyL6uGO6cs5ZILqxqlQIMUp-R6z3XB3pkx-t7G2QTrza4R4tbYmD10aCRQZmtLW6n1Ys6btmoZVqp2TnBguLA-7lnj1PToAIccbfcM-nwy-FuzDX8MY5Wky7MuhPMDIYbfE6Zsep8Au84OGKZkBCsrLWmp60X67qnZo8v_H1oEfC-AGFKK2D5KGDUPSTC7JJiHJJhDEsQ_IqiqkA |
Cites_doi | 10.1093/infdis/jis336 10.3390/ijms222111401 10.1080/21505594.2017.1313372 10.1146/annurev-med-080219-122208 10.1016/j.carbpol.2020.117108 10.1093/jac/dkv038 10.3390/toxins10100385 10.1111/jam.14769 10.1016/S1473-3099(18)30513-9 10.1016/j.chom.2016.12.005 10.1016/j.jep.2021.114133 10.3390/molecules22091430 10.3390/ijms231911740 10.1073/pnas.0606795103 10.1016/j.chembiol.2016.02.010 10.2147/IJN.S24805 10.1016/j.fct.2014.10.023 10.1186/s12877-022-03257-3 10.3109/13880200903573169 10.13758/j.cnki.tr.2020.05.004 10.1089/sur.2018.184 10.1021/np058069d 10.1038/s41579-018-0001-8 10.1016/j.bcp.2016.09.018 10.1016/j.cell.2005.02.033 10.3390/antibiotics7030066 10.1016/j.cmi.2019.09.015 10.1007/s12272-016-0824-7 |
ContentType | Journal Article |
Copyright | Copyright © 2024 Li, Wu, Hu, Meng and Xu. Copyright © 2024 Li, Wu, Hu, Meng and Xu. 2024 Li, Wu, Hu, Meng and Xu |
Copyright_xml | – notice: Copyright © 2024 Li, Wu, Hu, Meng and Xu. – notice: Copyright © 2024 Li, Wu, Hu, Meng and Xu. 2024 Li, Wu, Hu, Meng and Xu |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fphar.2024.1478135 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) (Open Access) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Li et al |
EISSN | 1663-9812 |
ExternalDocumentID | oai_doaj_org_article_5c01a7a0f5994202bf6f1e687dd32c1e PMC11650140 39691402 10_3389_fphar_2024_1478135 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c420t-c5dc7b7ceaf4bd0e0cb9fd8dd099e0e58833ab5cea46b2dd8a02523a8b88c9c53 |
IEDL.DBID | M48 |
ISSN | 1663-9812 |
IngestDate | Wed Aug 27 01:08:20 EDT 2025 Thu Aug 21 18:29:19 EDT 2025 Fri Jul 11 09:19:36 EDT 2025 Sun Mar 30 02:12:19 EDT 2025 Tue Jul 01 01:11:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | toxicity PLY glycyrol Streptococcus pneumoniae TCM |
Language | English |
License | Copyright © 2024 Li, Wu, Hu, Meng and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c420t-c5dc7b7ceaf4bd0e0cb9fd8dd099e0e58833ab5cea46b2dd8a02523a8b88c9c53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Josué Arturo Velázquez-Moyado, National Autonomous University of Mexico, Mexico Edited by: Carlos L. Cespedes-Acuña, University of Bio Bio Chillan Chile, Chile Reviewed by: Habibu Tijjani, National Open University of Nigeria, Nigeria |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2024.1478135 |
PMID | 39691402 |
PQID | 3146950497 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5c01a7a0f5994202bf6f1e687dd32c1e pubmedcentral_primary_oai_pubmedcentral_nih_gov_11650140 proquest_miscellaneous_3146950497 pubmed_primary_39691402 crossref_primary_10_3389_fphar_2024_1478135 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-12-03 |
PublicationDateYYYYMMDD | 2024-12-03 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in pharmacology |
PublicationTitleAlternate | Front Pharmacol |
PublicationYear | 2024 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Fang (B5) 2016 Qiu (B18) 2012; 206 Theuretzbacher (B24) 2019; 19 Vila (B26) 2020; 26 Zafar (B29) 2017; 21 Jarczak (B10) 2022; 23 Rashki (B19) 2021; 251 Rohde (B21) 2018; 19 Seil (B23) 2012; 7 Hatfull (B7) 2022; 73 Rhew (B20) 2016; 39 Alam (B2) 2016; 23 Huang (B9) 2020; 52 Molchanova (B14) 2017; 22 Li (B11) 2010; 48 Qi (B17) 2021; 130 Tilley (B25) 2005; 121 Domingo-Calap (B4) 2018; 7 Xu (B28) 2014; 74 Díez-Martínez (B3) 2015; 70 Guo (B6) 2021; 275 He (B8) 2006; 69 Weiser (B27) 2018; 16 Ageitos (B1) 2017; 133 Ouyang (B15) 2018; 10 Luo (B13) 2021; 22 Roy (B22) 2018; 9 Zhang (B30) 2022; 22 Pinkner (B16) 2006; 103 |
References_xml | – volume: 206 start-page: 292 year: 2012 ident: B18 article-title: Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of α-hemolysin publication-title: J. Infect. Dis. doi: 10.1093/infdis/jis336 – volume: 22 start-page: 11401 year: 2021 ident: B13 article-title: Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms222111401 – volume: 9 start-page: 522 year: 2018 ident: B22 article-title: Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action publication-title: Virulence doi: 10.1080/21505594.2017.1313372 – volume: 73 start-page: 197 year: 2022 ident: B7 article-title: Phage therapy for antibiotic-resistant bacterial infections publication-title: Annu. Rev. Med. doi: 10.1146/annurev-med-080219-122208 – volume: 251 start-page: 117108 year: 2021 ident: B19 article-title: Chitosan-based nanoparticles against bacterial infections publication-title: Carbohydr. Polym. doi: 10.1016/j.carbpol.2020.117108 – volume: 70 start-page: 1763 year: 2015 ident: B3 article-title: A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkv038 – volume: 10 start-page: 385 year: 2018 ident: B15 article-title: Erianin against Staphylococcus aureus infection via inhibiting sortase A publication-title: Toxins (Basel) doi: 10.3390/toxins10100385 – volume: 130 start-page: 843 year: 2021 ident: B17 article-title: Betulin attenuates pneumolysin-induced cell injury and DNA damage publication-title: J. Appl. Microbiol. doi: 10.1111/jam.14769 – volume: 19 start-page: e40 year: 2019 ident: B24 article-title: Analysis of the clinical antibacterial and antituberculosis pipeline publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(18)30513-9 – volume: 21 start-page: 73 year: 2017 ident: B29 article-title: Host-to-Host transmission of Streptococcus pneumoniae is driven by its inflammatory toxin, pneumolysin publication-title: Pneumolysin. Cell Host Microbe doi: 10.1016/j.chom.2016.12.005 – volume: 275 start-page: 114133 year: 2021 ident: B6 article-title: The TCM prescription Ma-xing-shi-gan-tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2021.114133 – start-page: 2 year: 2016 ident: B5 article-title: It’s time for the Chinese to say no to the abuse of antibiotics in animals and plants Chinese famous plant ecologist Jiang Gaoming talks about antibiotics in the ecological chain publication-title: Cap. Food Med. – volume: 22 start-page: 1430 year: 2017 ident: B14 article-title: Advances in development of antimicrobial peptidomimetics as potential drugs publication-title: Molecules doi: 10.3390/molecules22091430 – volume: 23 start-page: 11740 year: 2022 ident: B10 article-title: Cytokine storm-definition, causes, and implications publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms231911740 – volume: 103 start-page: 17897 year: 2006 ident: B16 article-title: Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0606795103 – volume: 23 start-page: 381 year: 2016 ident: B2 article-title: RecA inhibitors potentiate antibiotic activity and block evolution of antibiotic resistance publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2016.02.010 – volume: 7 start-page: 2767 year: 2012 ident: B23 article-title: Antimicrobial applications of nanotechnology: methods and literature publication-title: Int. J. Nanomedicine doi: 10.2147/IJN.S24805 – volume: 74 start-page: 311 year: 2014 ident: B28 article-title: Antitumor activity of glycyrol via induction of cell cycle arrest, apoptosis and defective autophagy publication-title: Food Chem. Toxicol. doi: 10.1016/j.fct.2014.10.023 – volume: 22 start-page: 562 year: 2022 ident: B30 article-title: Early use of probiotics might prevent antibiotic-associated diarrhea in elderly (>65 years): a systematic review and meta-analysis publication-title: BMC Geriatr. doi: 10.1186/s12877-022-03257-3 – volume: 48 start-page: 1177 year: 2010 ident: B11 article-title: Immunosuppressive activity on the murine immune responses of glycyrol from Glycyrrhiza uralensis via inhibition of calcineurin activity publication-title: Pharm. Biol. doi: 10.3109/13880200903573169 – volume: 52 start-page: 10 year: 2020 ident: B9 article-title: Research progress on the migration, transformation and resistance reduction of antibiotics/resistant bacteria/resistant genes in the soil-plant system publication-title: Soil doi: 10.13758/j.cnki.tr.2020.05.004 – volume: 19 start-page: 737 year: 2018 ident: B21 article-title: Bacteriophages: a therapy concept against multi-drug-resistant bacteria publication-title: Surg. Infect. (Larchmt) doi: 10.1089/sur.2018.184 – volume: 69 start-page: 121 year: 2006 ident: B8 article-title: Antibacterial compounds from Glycyrrhiza uralensis publication-title: J. Nat. Prod. doi: 10.1021/np058069d – volume: 16 start-page: 355 year: 2018 ident: B27 article-title: Streptococcus pneumoniae: transmission, colonization and invasion publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-018-0001-8 – volume: 133 start-page: 117 year: 2017 ident: B1 article-title: Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2016.09.018 – volume: 121 start-page: 247 year: 2005 ident: B25 article-title: Structural basis of pore formation by the bacterial toxin pneumolysin publication-title: Cell. doi: 10.1016/j.cell.2005.02.033 – volume: 7 start-page: 66 year: 2018 ident: B4 article-title: Bacteriophages: protagonists of a post-antibiotic era publication-title: Antibiot. (Basel). doi: 10.3390/antibiotics7030066 – volume: 26 start-page: 596 year: 2020 ident: B26 article-title: Current landscape in the discovery of novel antibacterial agents publication-title: Clin. Microbiol. Infect. doi: 10.1016/j.cmi.2019.09.015 – volume: 39 start-page: 1482 year: 2016 ident: B20 article-title: Synergic effect of combination of glycyrol and fluconazole against experimental cutaneous candidiasis due to Candida albicans publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-016-0824-7 |
SSID | ssj0000399364 |
Score | 2.3653724 |
Snippet | Exploring the potential of glycyrol to reduce the invasiveness of
(
).
Cell experiments were performed using A549 alveolar epithelial cells and
D39. Glycyrol... Exploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Aim of the studyExploring the potential of glycyrol... Aim of the studyExploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Materials and MethodsCell... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1478135 |
SubjectTerms | glycyrol Pharmacology PLY Streptococcus pneumoniae TCM toxicity |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yJy_i2_FFBFkUt9meTtKdHFVcF1GZwy6sF0Me1e7A2D3M9IDz761KZndmRPDitdNNF_VV6kEqXzH2so2hAa2wyAkyFNIIg3uuLIuqjUKhjQSVZh1--VqfnstPF-piZ9QX9YRleuCsuGMVyrFrXNkqYyRW6r6t2zHUuolRVGEM5H0x5u0UU8kHU9ytZb4lg1WYOW7nl474PyuJzqHR4zTfbRuJEmH_37LMP5sld6LPyW12a5M28rdZ3DvsBnR32eEk806vj_jZ9hrV8ogf8smWkXp9j33_OFuH9aKf8dz4veSTDlY_e6Ij6firyedvr3k_m_7o6fgm38vkQ88XROsKnA6u50OPnjOslnyevuymDvCVX9OAWfx9dn7y4ez9abEZrFAEVOFQBIUI-SaAa6WPJZTBmzbqGDFdhBIUDSB2XuG6rH0Vo3aYGVXCaa91MEGJB-yg6zt4xLjUyoMAIYRsJOrVCQGuRMxiVQejqhF7c6VkO8_8GRbrDoLEJkgsQWI3kIzYO8Lh-k3ivk4P0CLsxiLsvyxixF5coWhxr9ABiOugXy2twLBgFNZEzYg9zKhe_0qY2mCxiQLrPbz3ZNlf6aaXiY-bGIyoUH38P6R_wm6SRlLHjHjKDobFCp5h3jP458nEfwPjigQ0 priority: 102 providerName: Directory of Open Access Journals |
Title | Glycyrol targets Pneumolysin (PLY) oligomerization to reduce Streptococcus pneumoniae toxicity |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39691402 https://www.proquest.com/docview/3146950497 https://pubmed.ncbi.nlm.nih.gov/PMC11650140 https://doaj.org/article/5c01a7a0f5994202bf6f1e687dd32c1e |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKuXBB5b0UKiOhCkQD3thO7AOqCqJUiKI9dKVywfIr7UrbZJtkpebfM3ayLYvKhWtsJ858Hs-MH98g9LpwNveCQ5BjmU2YpBJ0jpAkLRzlMEYsj7kOj39kR1P27ZSfbqBVuqNBgM2toV3IJzWt5--vLrt9UPiPIeIEe_uhWJzrQO2ZMtD7XIwpv4PugmXKQ0aD48HdjzNzsMYZ6-_O_KPpmn2KNP63-Z5_H6H8wyYdbqH7gzOJD3r0H6ANXz5Eu5Oejbrbwyc3l6uaPbyLJzc81d0j9OvrvLNdXc1xfxy8wZPSLy-qQFJS4jeT7z_f4mo-O6vCpk5_WxO3Fa4D2avHYTt70VYwn9plgxexZTnTHqpczSz49o_R9PDLyeejZEi3kFiWkjaxHHAzufW6YMYRT6yRhRPOgRPpiechLbE2HMpZZlLnhAZ_KaVaGCGstJw-QZtlVfpnCDPBjaeeUspyBnLVlHpNLBm7NLOSpyP0biVktehZNRREIwESFSFRARI1QDJCnwIO1zUDI3Z8UNVnalAwxeHtOtek4FLC76SmyIqxz0TuHE3t2I_QqxWKCjQobIvo0lfLRlEwFpJDpJSP0NMe1etPUZlJCEGhw2IN77W-rJeUs_PI0h14jUL4-vz_m26je0EO8fQMfYE223rpX4IP1JqduHawE4f3b9ErDG0 |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycyrol+targets+Pneumolysin+%28PLY%29+oligomerization+to+reduce+Streptococcus+pneumoniae+toxicity&rft.jtitle=Frontiers+in+pharmacology&rft.au=Li%2C+Yudi&rft.au=Wu%2C+Hongji&rft.au=Hu%2C+Yibo&rft.au=Meng%2C+Haoji&rft.date=2024-12-03&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=15&rft_id=info:doi/10.3389%2Ffphar.2024.1478135&rft.externalDocID=PMC11650140 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |